Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 153.70
-3.35 (-2.13%)
At close: Jan 21, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 17.13 billion as of January 23, 2026. Its market cap has decreased by -2.55% in one year.
Market Cap
17.13B
Enterprise Value
16.01B
Revenue
8.60B
Ranking
n/a
PE Ratio
15.69
Stock Price
153.70
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 17.13B, an increase of 170,339.99%. That is a compound annual growth rate of 36.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 17.13B | -0.95% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unichem Laboratories | 26.21B |
| Hikal | 23.92B |
| Novartis India | 19.40B |
| Shukra Pharmaceuticals | 19.09B |
| Morepen Laboratories | 18.73B |
| Amrutanjan Health Care | 18.09B |
| TTK Healthcare | 13.88B |
| Kwality Pharmaceuticals | 11.52B |